Middle East Cancer Therapeutics Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

  • Therapy Type (Chemotherapy, Targeted Therapy, Radiation Therapy, Hormone Therapy, Other Therapy Types)
  • Indications (Blood Cancer, Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, Cervical Cancer, Liver & Intrahepatic Bile Duct Cancer, Thyroid Cancer, Other Indications)
  • Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channel)


No. of Pages: 150    |    Report Code: BMIRE00031447    |    Category: Life Sciences

Middle East Cancer Therapeutics Market
Buy Now

The cancer therapeutics market size is expected to reach US$ 4,842.33 million by 2031 from US$ 2,307.69 million in 2024. The market is estimated to record a CAGR of 10.5 % from 2025 to 2031. 

Executive Summary and Middle East Cancer Therapeutics Market Analysis:

The cancer therapeutics market in Middle East is experiencing significant growth driven by several key factors, including significant advancements in healthcare infrastructure and an increase in the prevalence of cancer. The region is known for its economic wealth, and it has made strides in developing its healthcare sector to meet the rising demands of its aging population. Owing to the continuous evolution of healthcare systems, rising cancer incidence, burgeoning government support, and an increased focus on cancer care, the Middle East region is experiencing substantial growth in the cancer therapeutics market. The demand for innovative cancer treatment modalities such as immunotherapies and personalized medicine is rising in Middle East countries, and investments in healthcare systems and awareness programs are aiding in improved access to these therapies.

Middle East Cancer Therapeutics Market Strategic Insights

global-market-strategic-framework
Get more information on this report

Middle East Cancer Therapeutics Market Segmentation Analysis

Key segments that contributed to the derivation of the cancer therapeutics market analysis are therapy type, indication, and distribution channel.

  • By therapy type, the cancer therapeutics market is segmented into chemotherapy, targeted therapy, radiation therapy, hormone therapy, and other therapy types. The chemotherapy segment dominated the market in 2024.
  • In terms of indications, the market is segmented into blood cancer, lung cancer, breast cancer, colorectum cancer, prostate cancer, stomach cancer, cervical cancer, liver and intrahepatic bile duct cancer, thyroid cancer, and other indications. The lung cancer segment held the largest share of the market in 2024.
  • By distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online stores. The hospital pharmacies segment held the largest share of the market in 2024.

Middle East Cancer Therapeutics Market Outlook

A significant rise in cancer cases in the region drives the need for cancer therapeutics in Middle East region. According to the GLOBOCAN 2022 Data, in 2022, ~4,347 new cancer cases were detected in Kuwait, among which breast cancer was the most prominent type, followed by colorectum cancer. As per the same source, the country recorded ~892 new breast cancer cases, representing 20.5% of all registered cases. The five-year prevalence rate for breast cancer in all ages was 211.30 per 100,000 population. It was also the major cause of cancer deaths in women, as it caused ~255 deaths in 2022.

Governments of various countries of the Middle East are investing heavily in healthcare infrastructure and cancer control programs. For instance, Qatar's government prioritizes healthcare as part of its National Vision 2030, which includes strengthening the country's healthcare system and promoting medical research. The Qatar Cancer Society, alongside institutions such as Hamad Medical Corporation (HMC), plays a crucial role in raising awareness and providing care. HMC's National Center for Cancer Care and Research (NCCCR) is a key facility offering advanced treatments, including chemotherapy, radiotherapy, and clinical trials for cancer patients. The Qatar Cancer Plan 2023–2026 sets out clear strategic objectives and deliverables to be accomplished by the end of 2026. These include a focus on key areas such as the development of palliative homecare services and precision medicine in cancer care. The cancer therapeutics market is expected to continue expanding in Qatar with these government initiatives and the burgeoning cancer burden.

Middle East Cancer Therapeutics Market Country Insights

Based on region, the Gulf Cooperation Council (Middle East) cancer therapeutics market is further segmented into Saudi Arabia, UAE, Kuwait, Oman, Qatar, and Bahrain. Saudi Arabia held the largest share in 2024.

The growth of the cancer therapeutics market in Saudi Arabia is driven by rising cancer incidence, growing healthcare infrastructure, and an increasing aging population. Saudi Arabia has been experiencing an upsurge in the incidence of cancer; the number of cancer-related deaths has also increased in the country. As per GLOBOCAN 2020 data, the country recorded ~27,885 new cancer cases, and the number is expected to rise to 60,429 by 2040. Also, the number of people aged 80 or more is expected to reach 1.6 million, i.e., 4% of the total population by 2050. Lifestyle changes such as increased tobacco use and poor dietary habits further elevate cancer risk in the Saudi population.

Middle East Cancer Therapeutics Market Report Highlights

Report Attribute Details
Market size in 2024 US$ 2,307.69 Million
Market Size by 2031 US$ 4,842.33 Million
Global CAGR (2025 - 2031) 10.5 %
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Therapy Type
  • Chemotherapy
  • Targeted Therapy
  • Radiation Therapy
  • Hormone Therapy
  • Other Therapy Types
By Indications
  • Blood Cancer
  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Stomach Cancer
  • Cervical Cancer
  • Liver & Intrahepatic Bile Duct Cancer
  • Thyroid Cancer
  • Other Indications
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Channel
Regions and Countries Covered Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Get more information on this report

Middle East Cancer Therapeutics Market Company Profiles

Astellas Pharma Inc; Eli Lilly and Co; Novartis AG; Merck KGaA.; Johnson & Johnson; AstraZeneca; Julphar Pharmaceuticals; Bristol Myers Squibb; SPIMACO ADDWAEIH; and Gulf Investment Corporation are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.

Middle East Cancer Therapeutics Market Research Methodology:

The following methodology has been followed for the collection and analysis of data presented in this report:

  • Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

  • Company websites, annual reports, financial statements, broker analyses, and investor presentations
  • Industry trade journals and other relevant publications
  • Government documents, statistical databases, and market reports
  • News articles, press releases, and webcasts specific to companies operating in the market

Note:

All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

  • Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:

  • Refine findings from secondary research
  • Enhance the expertise and market understanding of the analysis team
  • Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:

  • Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
  • External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Middle East Cancer Therapeutics Market Country and Regional Insights

middle-east-cancer-therapeutics-market
Get more information on this report

Middle East Cancer Therapeutics Key Sources Referred:

  • The World Bank World Development Indicators: Arab World
  • World Health Organization Regional Office for Eastern Mediterranean (WHO-EMRO)
  • Global Cancer Observatory
  • Qatar Cancer Society

 

The List of Companies - Middle East Cancer Therapeutics Market

Frequently Asked Questions
How big is the Middle East Cancer Therapeutics Market?

The Middle East Cancer Therapeutics Market is valued at US$ 2,307.69 Million in 2024, it is projected to reach US$ 4,842.33 Million by 2031.

What is the CAGR for Middle East Cancer Therapeutics Market by (2025 - 2031)?

As per our report Middle East Cancer Therapeutics Market, the market size is valued at US$ 2,307.69 Million in 2024, projecting it to reach US$ 4,842.33 Million by 2031. This translates to a CAGR of approximately 10.5 % during the forecast period.

What segments are covered in this report?

The Middle East Cancer Therapeutics Market report typically cover these key segments-

  • Therapy Type (Chemotherapy, Targeted Therapy, Radiation Therapy, Hormone Therapy, Other Therapy Types)
  • Indications (Blood Cancer, Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, Cervical Cancer, Liver & Intrahepatic Bile Duct Cancer, Thyroid Cancer, Other Indications)
  • Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channel)

What is the historic period, base year, and forecast period taken for Middle East Cancer Therapeutics Market?

The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East Cancer Therapeutics Market report:

  • Historic Period : 2021-2023
  • Base Year : 2024
  • Forecast Period : 2025-2031
  • Who are the major players in Middle East Cancer Therapeutics Market?

    The Middle East Cancer Therapeutics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Astellas Pharma Inc
  • Eli Lilly and Co
  • Novartis AG
  • Merck KGaA
  • AstraZeneca
  • Pfizer Inc
  • Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • AbbVie Inc
  • Bristol-Myers Squibb Co
  • Who should buy this report?

    The Middle East Cancer Therapeutics Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East Cancer Therapeutics Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now